Madhukar H. Trivedi, MD

Article

Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study

February 24, 2011

Read this article to examine results from a randomized, open-label, multicenter study that compared treatment outcomes with the serotonin-norepinephrine reuptake inhibitor venlafaxine extended release with selective serotonin reuptake inhibitors...

Madhukar H. Trivedi, Michael E. Thase, Philip T. Ninan, et al

Article

Measurement-Based Care in Psychiatric Practice: A Policy Framework for Implementation

January 11, 2011

Madhukar H. Trivedi, A. John Rush, Kelli Jane K. Harding, et al

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

August 16, 2010

Madhukar H. Trivedi, Herbert Y. Meltzer, Frederick K. Goodwin, et al

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

July 13, 2010

Madhukar H. Trivedi, Herbert Y. Meltzer, Frederick K. Goodwin, et al

Original Research

Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Report

June 15, 2010

David Mischoulon, Maurizio Fava, Madhukar H. Trivedi, et al

Original Research

Agomelatine in the Treatment of Major Depressive Disorder: An 8-Week, Multicenter, Randomized, Placebo-Controlled Trial

March 23, 2010

Maurizio Fava, Madhukar H. Trivedi, Stephen M. Stahl, et al

Original Research

Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression: Rapid Onset of Therapeutic Response and Its Predictive Value for Subsequent Overall Response in a Pooled Analysis of 5 Studies

February 23, 2010

Madhukar H. Trivedi, Michael E. Thase, Mauricio Tohen, et al

Original Research

Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163)

December 17, 2009

Maurizio Fava, Ronald N. Marcus, Madhukar H. Trivedi, et al

Original Research

Family History of Depression and Therapeutic Outcome: Findings From STAR*D

December 2, 2009

Maurizio Fava, Andrew A. Nierenberg, Madhukar H. Trivedi, et al

Article

Tools and Strategies for Ongoing Assessment of Depression: A Measurement-Based Approach to Remission

November 15, 2009

Madhukar H. Trivedi

Original Research

Do Depressed Patients With Diabetes Experience More Side Effects When Treated With Citalopram Than Their Counterparts Without Diabetes? A STAR*D Study

November 10, 2009

Maurizio Fava, Madhukar H. Trivedi, Michael E. Thase, et al

Educational Activity

Treating Partial Responders to Antidepressant Treatment

September 15, 2009

Madhukar H. Trivedi

Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study

Measurement-Based Care in Psychiatric Practice: A Policy Framework for Implementation

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Report

Agomelatine in the Treatment of Major Depressive Disorder: An 8-Week, Multicenter, Randomized, Placebo-Controlled Trial

Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression: Rapid Onset of Therapeutic Response and Its Predictive Value for Subsequent Overall Response in a Pooled Analysis of 5 Studies

Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163)

Family History of Depression and Therapeutic Outcome: Findings From STAR*D

Tools and Strategies for Ongoing Assessment of Depression: A Measurement-Based Approach to Remission

Do Depressed Patients With Diabetes Experience More Side Effects When Treated With Citalopram Than Their Counterparts Without Diabetes? A STAR*D Study

Treating Partial Responders to Antidepressant Treatment

ELSEWHERE:

FOLLOW US:

Madhukar H. Trivedi, MD

Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study

Measurement-Based Care in Psychiatric Practice: A Policy Framework for Implementation

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Report

Agomelatine in the Treatment of Major Depressive Disorder: An 8-Week, Multicenter, Randomized, Placebo-Controlled Trial

Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression: Rapid Onset of Therapeutic Response and Its Predictive Value for Subsequent Overall Response in a Pooled Analysis of 5 Studies

Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163)

Family History of Depression and Therapeutic Outcome: Findings From STAR*D

Tools and Strategies for Ongoing Assessment of Depression: A Measurement-Based Approach to Remission

Do Depressed Patients With Diabetes Experience More Side Effects When Treated With Citalopram Than Their Counterparts Without Diabetes? A STAR*D Study

Treating Partial Responders to Antidepressant Treatment

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles